Non-stented pancreaticogastrostomy after pylorus-preserving pancreaticoduodenectomy
- PMID: 12201565
Non-stented pancreaticogastrostomy after pylorus-preserving pancreaticoduodenectomy
Abstract
Background: We hypothesized that neutralization of the gastric acidity by alkaline pancreatic secretion via a non-stented pancreaticogastrostomy after pylorus-preserving pancreaticoduodenectomy (non-stented PPPD-PG) might provide protection against marginal or stress ulcer. Surgical risk of non-stented pancreaticogastrostomy was also assessed to clarify the importance of stenting in pancreatic anastomosis.
Methods: From January 1997 to December 2000, 54 patients with resectable periampullary lesions were included for non-stented PPPD-PG. Gastric pH and amylase levels were measured on the postoperative day 7. Surgical risks including pancreatic leakage, morbidity and mortality were also assessed.
Results: Patients undergoing the non-stented PPPD-PG presented significantly higher gastric levels of pH and amylase than healthy patients as controls (median pH 5.0 vs 2.8, p = 0.007; and median amylase 7,660 vs 21 IU/L, p = 0.031). Among the patients undergoing the non-stented PPPD-PG, low gastric pH and amylase levels were associated with high gastric drainage group > or = 600 c.c./day. However, only 1 of the 18 patients with low gastric amylase level (high gastric drainage group) developed significant steatorrhea and needed replacement of concentrated pancreatic enzymes. There were 18 (33.3%) complications and 1 (1.8%) mortality. The cause of death was cardiac arrythmia, not related to operation. Gastric atonia was the most common complication (18.5%), followed by wound infection, intraabdominal abscess, and intraabdominal bleeding in 2 patients (5.6%) individually. No pancreatic leakage or ulcer-related complication occurred after non-stented PPPD-PG.
Conclusions: Experience of no pancreatic leakage in our 54 non-stented PPPD-PG implies that stenting of pancreaticogastrostomy might not be crucial in prevention of pancreatic leakage and ductal occlusion. Moreover, non-stented PPPD-PG can increase gastric pH and amylase levels, which might be beneficial in protection against marginal ulceration.
Similar articles
-
Gastric pH and amylase and safety for non-stented pancreaticogastrostomy.Hepatogastroenterology. 2002 Nov-Dec;49(48):1747-50. Hepatogastroenterology. 2002. PMID: 12397784
-
Non-stented pancreaticogastrostomy for 111 patients undergoing pylorus-preserving pancreaticoduodenectomy.Hepatogastroenterology. 2005 Jan-Feb;52(61):253-7. Hepatogastroenterology. 2005. PMID: 15783043
-
Gastric acidity following pancreaticogastrostomy with pylorus-preserving pancreaticoduodenectomy.World J Surg. 2000 Jan;24(1):86-90; discussion 90-1. doi: 10.1007/s002689910016. World J Surg. 2000. PMID: 10594209
-
The impact of pylorus-preserving pancreatoduodenectomy on surgical treatment for cancer of the pancreatic head.J Hepatobiliary Pancreat Surg. 2002;9(2):223-32. doi: 10.1007/s005340200023. J Hepatobiliary Pancreat Surg. 2002. PMID: 12140611 Review.
-
[Evidence based surgery of cancer of head of pancreas].Bull Acad Natl Med. 2004;188(5):743-52; discussion 753-4. Bull Acad Natl Med. 2004. PMID: 15656235 Review. French.
Cited by
-
Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons.J Gastrointest Surg. 2015 Apr;19(4):604-12. doi: 10.1007/s11605-015-2765-8. Epub 2015 Feb 18. J Gastrointest Surg. 2015. PMID: 25691111 Review.